McArdle Grace 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2026
Insider Transaction Report
Form 4
McArdle Grace
EVP, MANUFACTURING AND QUALITY
Transactions
- Award
Common Stock
2026-03-01+30,110→ 106,159 total - Tax Payment
Common Stock
2026-03-01$26.40/sh−12,337$325,697→ 93,822 total - Award
Common Stock
[F1]2026-03-01+14,205→ 108,027 total - Award
Employee Stock Option (right to buy)
[F2]2026-03-01+29,025→ 29,025 totalExercise: $26.40Exp: 2036-03-01→ Common Stock (29,025 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
- [F2]Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Grace McArdle|2026-03-03